Diffuse Large B-cell Lymphoma: Clinical Trials

4 trials for Diffuse Large B-cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 active not recruiting, 1 recruiting. 4 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 14Unknown 2, Active not recruiting 1, Recruiting 1

Follow Diffuse Large B-cell Lymphoma: new trials by email Literature Review of Diffuse Large B-cell Lymphoma trials Research Report on Diffuse Large B-cell Lymphoma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research
Metabolically Armed CD19 CAR-T cells - Diffuse Large B-cell Lymphoma
Early Phase 1RecruitingHe Huang182023-11-162025-09-19
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research
Metabolically Armed CD19 CAR-T cells - Diffuse Large B-cell Lymphoma
Early Phase 1UnknownAnhui Provincial Hospital182023-02-102023-07-05
A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
RD14-01 cell infusion - Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma
Early Phase 1UnknownHe Huang182022-07-052022-07-11
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
131-I Apamistamab, CAR T-cell - B-ALL, DLBCL
Early Phase 1Active not recruitingMemorial Sloan Kettering Cancer Center112021-02-022026-11-06

Narrower conditions

Lymphoma, Large B-Cell, Diffuse (4)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Pyloric Stenosis, Hypertrophic (1)

Broader conditions

Hemic and Lymphatic Diseases (4)  ·  Immune System Diseases (4)  ·  Immunoproliferative Disorders (4)  ·  Lymphatic Diseases (4)  ·  Lymphoma (4)  ·  Lymphoma, B-Cell (4)  ·  Lymphoma, Non-Hodgkin (4)  ·  Lymphoproliferative Disorders (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Digestive System Diseases (1)  ·  Gastric Outlet Obstruction (1)  ·  Gastrointestinal Diseases (1)  ·  Pyloric Stenosis (1)  ·  Stomach Diseases (1)

Interventions

Immunotherapy, Adoptive (1)

Sponsors

He Huang (2)  ·  Anhui Provincial Hospital (1)  ·  Memorial Sloan Kettering Cancer Center (1)

Countries

China (3)  ·  United States (1)

Top investigators

Mark B Geyer, MD (1)

Results publications

PMID 42490071